All In Biotech

Drug Trial Radar · NCT01713426

A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment

Qutenza Versus Pregabalin in Subjects With Peripheral Neuropathic Pain: an Open-label, Randomized, Multicenter, Non-inferiority Efficacy and Tolerability Study

Last checked: Nov 20, 2026Latest source record: Apr 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 568 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

568

Actual

Start

Jul 11, 2012

Primary completion

Sep 26, 2013

Study completion Sep 26, 2013

Sponsor

Lead sponsor
Astellas Pharma Europe Ltd.Astellas (ALPMY)
Sponsor type
Industry
First posted
Oct 24, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is comparing the efficacy and tolerability of Qutenza with that of pregabalin in patients suffering from peripheral neuropathic pain. Treatment allocation will be to one of these treatments and the duration of the study will be about 10 weeks (assuming that from screening to treatment allocation takes 2 weeks). Participants will be asked to complete questionnaires about various aspects relating to their condition throughout the study. This study will include subjects suffering from Postherpetic Neuralgia, Peripheral Nerve Injury or Non Diabetic peripheral polyneuropathy.

Conditions

  • Non-diabetic Painful Peripheral Polyneuropathy
  • Postherpetic Neuralgia (PHN)
  • Peripheral Nerve Injury (PNI)

Interventions

  • QutenzaDrug

    Cutaneous patch

  • PregabalinDrug

    Oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects in each arm who achieve at least 30% decrease in the "average pain for the past 24 hours" Numeric Pain Rating Scale (NPRS) score from baseline to week 8Time frame: Baseline and week 8

Locations

98 sites in 22 countries. Site status is shown where the registry gives one.

  • Site 101 Medical Union 2

    Yerevan, Armenia

  • Site 102 Medical Center Erebuni

    Yerevan, Armenia

  • Site 103 Scientific research Institute of physiotherapy

    Yerevan, Armenia

  • Site 104 Medical Center "Surb Nerses Mets"

    Yerevan, Armenia

  • Site 116 Krankenhaus der Barmherzigen B

    Graz, Austria

  • Site 111 AKH Universitatsklinik

    Vienna, Austria

  • Site 112 Wilhelminenspital

    Vienna, Austria

  • Site 114 Klinikum Klagenfurt Worthersee

    Klagenfurt, Carynthia, Austria

  • Site 115 Medical University Innsbruck

    Innsbruck, Tyrol, Austria

  • Site 121 Vitebsk Regional Clinical Hospital # 1

    Vitebsk, Belarus

  • Site 131 UZ Brussels

    Brussels, Belgium

  • Site 138 Cliniques Universitaires Saint

    Brussels, Belgium

  • Site 134 Grand Hospital de Charleroi

    Charleroi, Belgium

  • Site 137 Univ. Ziekenhuis Antwerpen

    Edegem, Belgium

  • Site 132 Ziekenhuis Oost-Limburg

    Genk, Belgium

  • Site 136 UZ Pellenberg

    Pellenberg, Belgium

  • Site 133 Heilig Hart Ziekenhuis

    Roeselare, Belgium

  • Site 142 UMHAT - Pleven

    Pleven, Bulgaria

  • Site 141 Centre for Mental Health

    Rousse, Bulgaria

  • Site 144 Tokuda Hospital Sofia

    Sofia, Bulgaria

  • Site 146 MHAT Alexandrovska Hospital

    Sofia, Bulgaria

  • Site 147 MHAT Sv. Ivan Rilski

    Sofia, Bulgaria

  • Site 145 Military Medical Academy

    Sofia, Bulgaria

  • Site 151 Fakultni nemocnice Plzen

    Pilsen, Czechia

  • Site 153 Klinika anesteziologie

    Prague, Czechia

  • Site 163 ORTON Invalidisaatio

    Helsinki, Finland

  • Site 161 Finnmedi OY

    Tampere, Finland

  • Site 162 Vassa Central Hospital

    Vaasa, Finland

  • Site 171 Hospital Ambroise Pare

    Boulogne-Billancourt, France

  • Site 174 Hopital Neurologique Pierre W

    Bron, France

  • Site 177 Hospital Roger Salengro CHRU

    Lille, France

  • Site 175 CHU Caremeau

    Nîmes, France

  • Site 172 Hospital Saint Antoine

    Paris, France

  • Site 173 CHU Hopital Nord

    Saint-Etienne, France

  • Site 176 CH Regional de Valence

    Valence, France

  • Site 200 Prax S.Wolf u.B.Schütz Pal.med

    Cottbus, Germany

  • Site 192 Universitätsklinikum Giessen

    Giessen, Germany

  • Site 193 Universitätsklinikum Münster

    Münster, Germany

  • Site 194 Schmerz Palliativznt Wiesbaden

    Wiesbaden, Germany

  • Site 197 Universitätsklinikum Würzburg

    Würzburg, Germany

Showing 40 of 98 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.